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Postthrombotic syndrome after isolated calf deep
venous thrombosis: The role of popliteal reflux
Jukka P. Saarinen, MD, Kati Domonyi, MD, Rainer Zeitlin, MD, and Juha-Pekka Salenius, MD,
Tampere, Finland
Objective: The purpose of this study was to evaluate the long-term clinical and hemodynamic outcomes after isolated
first-time calf deep venous thrombosis (cDVT).
Methods: This retrospective clinical study was set in an academic referral center. From 1990 to 1994, 617 patients were
seen with acute DVT. This number included 82 patients with phlebographically confirmed cDVT. Of those patients, 50
attended the clinical assessment 6 to 10 years (mean, 8.4 years) after the acute event. All patients with cDVT underwent
treatment with anticoagulant therapy (96% heparin and warfarin, 4% only warfarin). The duration of the heparin
treatment was 4.0 to 8.0 days (mean, 6.4 days), and warfarin was given for 2.0 to 7.5 months (mean, 3.4 months).
Compression stockings were used regularly (mean, 9.2 months; range, 0.25 to 64 months) in 30% of the patients after
acute cDVT. The initial ipsilateral phlebograms were reevaluated to confirm the diagnosis of cDVT without popliteal
involvement. The clinical assessment included evaluation of both legs according to CEAP clinical classification C0-6.
Bilateral color-flow duplex scan imaging was performed to assess reflux in deep popliteal segments. Photoplethysmo-
graphic measurement of venous refilling time was conducted in both legs to observe deep reflux.
Results: The mean age was 57 years (range, 30 to 76 years) at the time of the clinical assessment. Cause of acute cDVT was
idiopathy in 52%, coagulopathy in 2%, trauma in 10%, immobilization in 22%, and postoperative in 14% of the cases.
During the follow-up period, seven recurrent DVTs (14%) were seen. In the clinical assessment, 17 legs (34%) with
previous cDVT had skin changes (CEAP C4-6). No active ulcers were found. Contralaterally, the frequency of C4-6 was
10% (n  5; P < .05). After exclusion of recurrent DVTs, the distribution of the clinical classification still remained the
same. Deep popliteal reflux was detected in 20 legs (40%) with previous cDVT. Contralaterally, popliteal reflux was seen
in nine cases (18%; P < .05). Plethysmography showed deep reflux in 16 legs (33%) with cDVT and in nine cases (18%)
contralaterally (P > .05). A significant association was found between deep popliteal reflux and skin changes (P < .05).
Conclusion: In the long-term follow-up, cDVT may lead to significant postthrombotic disease. Reflux in the primarily
uninvolved popliteal vein is frequent and may be associated with more severe disease. (J Vasc Surg 2002;36:959-64.)
The outcome of isolated calf deep venous thrombosis
(cDVT) has continued to be a controversial subject.1 In
general, the possibilities of prediction of the severity of late
sequelae after an acute thrombotic event are limited.2 Pre-
vious long-term follow-up studies have shown a relatively
low incidence rate of postthrombotic syndrome after
cDVT.3,4 On the other hand, propagation of thrombus to
proximal veins from the calf may occur during adequate
therapeutic anticoagulation.5-7 Late reflux in initially unin-
volved venous segments has been observed in prospective
studies with patients with cDVT,8,9 and the same phenom-
enon has been noted after more proximal thrombosis.10
The aim of this study was to observe the long-term
outcome of isolated cDVT. This study focused on clinical
and hemodynamic features in these patients. The impor-
tance of the distal outflow tract was observed with detec-
tion of the valvular function in the deep popliteal segment.
The presence of deep reflux was assessed with photople-
thysmographic measurements. The clinical status of the
limb was estimated with standardized clinical classification.
MATERIAL AND METHODS
The study design was approved by a local ethics com-
mittee, and written informed consent was received. Acute
DVT had been detected in 617 consecutive patients from
1990 to 1994 in a university hospital. The records of these
patients were completely reviewed. Eighty-two patients
had phlebographically confirmed cDVT without history of
previous ipsilateral DVT. Two patients had had contralat-
eral DVT previously. The initial ipsilateral phlebograms of
these 82 cDVTs were reviewed for two main reasons: 1, to
ensure that venous thrombosis was limited to calf veins
without involvement into popliteal vein; and 2, to assess the
involvement of venous thrombosis in deep vein pairs of the
calf. The patients with gastrocnemius or soleal vein throm-
bosis were excluded from the data. All patients who were
alive were asked for a follow-up study, and 50 patients
agreed to attend for clinical assessment. Six patients had
moved to another hospital district, two were not reached,
and the remaining 24 patients refused to participate. In the
clinical assessment, the legs were bilaterally examined 6 to
10 years after the initial event (mean, 8.4 years) with the
following methods.
Clinical examination. The clinical examination in-
cluded inspection and palpation of the legs in the standing
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position. Trunk varicosities, edema, pigmentation, indura-
tion, and healed or active ulceration were recorded. The
patients were classified into clinical classifications 0 to 6
according to CEAP classification.11 Classification C0 rep-
resented legs with no signs of venous disease. Reticular
veins were considered to represent class C1. Trunk varicos-
ities (tortuous dilatation 4 mm in the area of great or
small saphenous vein or their tributaries) without edema or
skin changes were defined to represent classification C2.
Edema in the leg raised the clinical classification into C3.
Leg edema was detected if more than a 2-cm difference in
circumferences above ankles was seen or if a palpable pitting
edema was seen bilaterally. Skin changes typical for venous
disease (hyperpigmentation or eczema) were observed, and
in positive cases, the patient was classified into classification
C4. Small and sporadic skin changes were excluded. The
signs of healed ulcerations or an open ulceration during the
examination were defined to represent classifications C5
and C6. Estimation of the role of leg pain in CEAP classi-
fication is difficult, and therefore, it was not included in the
analysis. Clinical disability scoring was used to estimate the
grade of leg symptoms. Asymptomatic patients were classi-
fied into classification 0. Symptomatic patients who man-
aged without compression therapy were recorded into clas-
sification 1. If the leg symptoms caused a need for regular
use of compression to maintain the daily activities, the
patient was classified into classification 2. Classification 3
represented patients who were unable to perform daily
activities even with compression therapy.
The use of compression stockings after the initial cDVT
was assessed. The cause and side of the initial cDVT and the
diagnostic method and the location of the recurrent DVT
were recorded. Risk factors for DVT were recorded, includ-
ing malignant disease, estrogen therapy, trauma, immobi-
lization, and surgery. Concomitant diseases, such as coro-
nary heart disease, cardiac insufficiency, hypertension,
cerebrovascular disease, renal insufficiency, chronic lung
disease, and peripheral arterial disease, were recorded. Fur-
thermore, the length of treatment with anticoagulants was
assessed. The level of anticoagulant treatment was not
assessed because this treatment was given in healthcare
centers.
Color-flow duplex scan imaging. Ultrasound scan
studies (Toshiba Powervision 6000, Otawara, Japan) were
performed by a single surgeon experienced with venous
ultrasound scan imaging. A linear transducer operating at
the frequency of 7.5 MHz was used in all examinations.
The patient was studied in a standing position, and the
examined leg was maintained in a non–weight bearing
position during the measurement. The distal popliteal vein
was imaged in a longitudinal view, in most cases above the
origin of the short saphenous vein. The measurement for
observation of reversal flow in the popliteal vein was made
with distal manual compression-release of the calf. The
reversal flow was considered to be reflux if the retrograde
flow lasted more than 0.5 seconds. The exact duration of
retrograde flow was recorded.
Photoplethysmography. Plethysmographic mea-
surements were performed by vascular nurses trained to use
this method (Nicolet Vasoguard, Bristol, United King-
dom). The patients sat in a chair during the measurements.
The probe was placed above the medial malleolus on both
sides. After 10 regular tiptoe movements, the venous refill-
ing time (VRT) was observed bilaterally. If the VRT was
less than 18 seconds, the result was considered to be
abnormal. The test then was continued with application of
tourniquets in the calf. These tourniquets were inflated up
to 60 mm Hg, and the tiptoe movements were repeated.
VRT was observed as in the earlier phase. If the VRT
remained to be less than 18 seconds despite the occlusion of
the superficial veins with a tourniquet, the result was de-
fined to reflect deep reflux in the leg. In one case, the
subject was not able to perform the tiptoe movements
because of pain and rigidity in the ankle and therefore VRT
was not measured.
Statistical methods. The statistical comparisons were
made with the 2 method. Statistical significance was de-
fined as a P value of less than .05.
RESULTS
The mean age of the patients at the time of the clinical
assessment was 57 years (range, 30 to 76 years), and 56%
were female. In the acute phase, the left leg was slightly
more frequently involved (56%) than the right leg. In most
cases (64%), cDVT was located in one of the three deep vein
segments. In these cases, the most common single segment
containing thrombus was peroneal vein (56%), whereas
posterior tibial vein was affected in 38% and anterior tibial
in 6% of the cases. Only seven patients (14%) had cDVT in
all three deep pairs (peroneal, posterior tibial, and anterior
tibial).
Cause of acute cDVT was idiopathic in 26 patients
(52%). Coagulopathy was observed in one patient (2%)
who was found to have activated protein C resistance.
Cause was considered to be transient in 23 patients (46%),
including five cDVTs (10%) with trauma and 11 cDVTs
(22%) with immobilization and seven (14%) postoperative
cDVTs. Forty-one patients (82%) had no significant con-
comitant diseases. Two cases of coronary heart disease, four
cases of hypertension, two cases of cerebrovascular disease,
and one case with a combination of coronary heart disease
and hypertension were seen. Estrogen therapy was detected
in six patients (12%). No cases were seen of malignant
disease, peripheral artery disease, or pregnancy.
The management of an acute cDVT consisted of hep-
arin and warfarin in 48 of the patients (96%), and two
patients (4%) were treated with warfarin alone. The dura-
tion of the heparin treatment was 4.0 to 8.0 days (mean,
6.4 days), and warfarin was given for 2.0 to 7.5 months
(mean, 3.4 months). The treatment was given in the hos-
pital; outpatient treatment was not used. Routine screening
for coagulation disorders was not used. From 1990 to
1994, no systematic treatment with compression stockings
after DVT was used at our institution. Only 15 of the
patients (30%) had regular use of compression treatment
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(mean, 9.2 months; range, 0.25 to 64). Furthermore, the
use of stockings was not controlled and the grade of pres-
sure and the type of the stockings were not standardized.
Objectively verified recurrent DVT was noted in seven
patients (14%) during the follow-up period. In four cases,
the recurrent event occurred in the contralateral extremity.
In three cases with ipsilateral recurrence, the thrombus was
located into the calf venous segments in two patients and
into the deep femoropopliteal venous segment in one pa-
tient. These events are described in detail in Table I.
In the legs with previous cDVT, 17 cases (34%) were
classified into CEAP C4-6 in the clinical assessment. Of
them, two patients had signs of healed ulcer. No active
ulcers were found. Contralaterally, the number of legs
classified into CEAP C4-6 was five (10%), and one patient
had CEAP C5 disease because of a healed ulcer. The
difference between legs with CEAP C4-6 was statistically
significant (P  .05). CEAP C2-3 was observed in 12
patients (24%) and CEAP C0-1 in 21 patients (42%) with
previous cDVT. In the contralateral leg, these numbers
were 13 (26%) and 32 (64%), respectively. The difference
was significant inside classification CEAP C0-1 (P  .05),
but no difference was found in legs with trunk varicosity or
edema (C2-3). In total, 26 patients (52%) had manifest
postthrombotic signs (CEAP C3-6) in the group with
previous cDVT. When secondary events were excluded
from the analysis, the difference between legs inside the
group with CEAP C4-6 remained. These results are sum-
marized in Figs 1 and 2.
The mean of the clinical disability score in the patients
with previous cDVT was 0.8. The score was 1.3 in the
subgroup of patients with CEAP 3-6. No cases of classifi-
cation 3 were seen among the study population. The dis-
tribution of the clinical disability score was significantly
different between CEAP subgroups, as shown in Table II.
Deep popliteal reflux was observed in 20 cases (40%)
with previous cDVT. The duration of reflux was 0.5 to 0.99
seconds in six cases (30%), 1.0 to 1.99 seconds in 12 cases
(60%), and more than 2.0 seconds in the remaining two
cases (10%). In the contralateral leg, deep popliteal reflux
was detected in nine patients (18%). This difference be-
tween extremities was significant (P  .05). Photoplethys-
mographic measurements revealed deep venous reflux in 16
patients (33%) with previous cDVT. In the contralateral
side, deep reflux was detected in nine cases (18%; P .05).
Deep popliteal reflux was strongly associated with clin-
ical classification C4-6 (P  .05) in the leg with previous
cDVT, as shown in Table III. This association also was
observed after exclusion of the secondary DVTs (P  .05;
Table IV). In the contralateral extremity, an association
between popliteal reflux and clinical classification C4-6 was
similarly noted with and without secondary DVTs (P 
.05). Plethysmography showed a tendency but no signifi-
cance between deep reflux and skin changes (Table V).
However, a significant association was seen between deep
popliteal reflux in color-flow duplex scan imaging and deep
reflux in plethysmography (Table VI).
DISCUSSION
This study aimed to observe long-term clinical and
hemodynamic manifestations after cDVT. Factors that af-
fect the outcome after acute DVT have been difficult to
establish.2 Several studies have shown that the incidence of
the postthrombotic syndrome is quite equal when distal
and more proximal DVTs are compared.12-14 It has been
argued that an isolated cDVT may be treated without
anticoagulant therapy in cases with no propagation into
proximal veins.1,8 Several hemodynamic events may occur
after DVT, but their significance to late outcome is poorly
defined, such as propagation into proximal segments after
cDVT,6 reflux in the initially uninvolved segments,10 and
recurrent DVT.5 Permanent obstruction is a rare phenom-
enon after distal thrombosis. Recanalization occurs fre-
quently during a short time period.8,9 In iliofemoral DVT,
the thrombus may not resolve in the proximal segments or
this process is slow.15
The most striking finding in these data is the high
frequency of postthrombotic skin changes after cDVT.
Hyperpigmentation or eczema was observed in one third of
the patients after cDVT. The clinical disability score was
relatively high in those patients classified into CEAP clinical
classifications C3-6. On the other hand, no active ulcers
were found in this subgroup, and only two patients were
classified into CEAP C5 because of a healed ulcer. Franzeck
and colleagues3 followed 13 patients with previous cDVT.
They observed minor skin changes in 15% of the patients.
Other prospective studies have shown low rates of skin
complications, too.4,8,16 These data describe the 8-year
outcome with a sample of 50 cDVTs. The clinical evalua-
tion was based on CEAP classification.11 The more detailed
classification, venous clinical score system17 was published
during this survey, and inclusion of this system was not
possible in collection of these data.
These data show that postthrombotic symptoms and
signs may occur quite frequently in the contralateral leg.
However, contralateral phlebograms were not performed
at the time of cDVT diagnosis. This restricts the possibili-
ties of estimation of the outcome in the contralateral side.
The proportion of legs with skin changes was 10% in the
contralateral side, but the difference between legs remained
significant. In the cross-sectional population-based study in
Edinburgh, skin changes, including ulcers, were observed
in 6% of an adult population.18 In these data, the difference








Male Ipsilateral Calf Phlebography
Male Ipsilateral Calf Phlebography
Female Ipsilateral Femoral-popliteal Phlebography
Female Contralateral Calf Phlebography
Female Contralateral Calf Phlebography
Female Contralateral Femoral-popliteal Duplex scan imaging
Male Contralateral Popliteal Phlebography
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between legs becomes apparent only in cases with clinical
classification C4-6, whereas edema and varicose veins
(C2-3) were found quite equally. The classic study by
Browse, Clemenson, and Thomas19 showed a high propor-
tion (32%) of symptoms of the contralateral leg. Lindhagen
et al12 also observed postthrombotic symptoms and signs in
one third of patients without previous DVT in the leg. In
this material, secondary DVT was ipsilateral only in three
cases and was contralateral in four cases. Furthermore,
Fig 1. Clinical classification according to CEAP classification in both legs 6 to 10 years after unilateral cDVT.
Fig 2. Clinical classification according to CEAP classification in both legs 6 to 10 years after unilateral cDVT.
Recurrent DVTs excluded.
Table II. Clinical disability score in legs with previous












Table III. Presence of popliteal reflux after cDVT in
patients with and without postthrombotic skin changes.
Measurements are made with color-flow duplex scan









Reflux 8 (24%) 12 (71%)
No reflux 25 (76%) 5 (29%)
Total 33 (100%) 17 (100%)
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these figures represent only clinically manifest secondary
DVTs. Estimation of the role of silent recurrences during
the follow-up period is not possible.
The frequency of popliteal reflux after cDVT was high
in these data. The proportion of popliteal reflux was in-
creased in the contralateral leg as well. The Edinburgh vein
study showed reflux in deep popliteal segments in 10% to
12% of the adult participants.20 Previous studies have
shown that reflux may be detected in venous segments with
no thrombus involvement initially.10 A similar finding was
made by Masuda et al8 when they established a 3-year
follow-up with a sample of 23 cDVTs. They detected
popliteal reflux in several patients during the follow-up
period. Previous studies with duplex scanning also have
shown that propagation may occur into the proximal ve-
nous tree, but the role of these events on outcome has
remained unclear.6,7 In this material, all patients were
treated with anticoagulants. Anticoagulation therapy does
not completely prevent occult thrombus propagation.5,6
Reflux may occur even in 50% of the initially uninvolved
popliteal segments with thrombus propagation.5 In these
data, most patients did not receive compression treatment.
The role of compression in prevention of postthrombotic
syndrome has been clearly shown in patients with proximal
DVT,21 but the role of compression on outcome after
cDVT has been unclear.
Popliteal reflux seemed to be significantly more com-
mon in those patients with skin changes in these data. The
association between popliteal reflux and ambulatory venous
pressure has been shown by Shull and colleagues.22 A high
proportion of distal deep reflux in postthrombotic legs has
been observed by other investigators as well.13,23 However,
despite skin changes, the incidence rate of venous ulcer-
ation during the 8-year follow-up time was low in this
material. In plethysmographic measurements, deep reflux
was detected in 33% of the patients, but this finding was
relatively common (18%) in the contralateral side, too.
Masuda et al8 detected air-plethysmographic abnormalities
in 27% of the patients after cDVT, but the result did not
differ from that of control subjects.8 Heldal and col-
leagues13 found an extremely high proportion of deep
reflux in invasive measurements (60%) in a sample of 10
cDVTs with a 7-year follow-up.
The rate of symptomatic and objectively verified sec-
ondary DVT was 14% in these data. Prandoni et al24
showed the importance of the secondary events on out-
come. Lagerstedt and colleagues25 showed a high rate of
symptomatic recurrences after cDVT in the subgroup of
patients not treated with warfarin. On the other hand, the
frequency of symptomatic secondary DVT has been low
after cDVT in patients treated with anticoagulants for 6
weeks.26,27 Prolonged treatment showed no significant
benefit in this respect in a randomized trial.27 However,
these trials were not able to observe the occult secondary
events after cDVT. In this trial, the duration of anticoagu-
lant treatment was about 3 months, but the optimal level of
anticoagulant treatment has not been observed. The symp-
tomatic recurrent DVTs seem to have no impact on clinical
classification 6 to 10 years after cDVT in these data.
The results of this study differ from several previous
studies. The most surprising findings were the high rate of
legs with skin changes and the high proportion of popliteal
reflux. The study design was retrospective, and this way of
analysis is always more sensitive to selection bias, and all
patients who fulfilled the study criteria did not accept
participation. In a retrospective analysis, the baseline data
cannot be obtained, and therefore, estimation of the rate of
skin changes or the presence of superficial insufficiency at
the time of acute cDVT was not possible. In addition, the
presence of popliteal reflux in the acute phase cannot be
excluded because the reexamination of the phlebograms
only confirmed that each popliteal vein was free of throm-
bus. The lack of baseline data in the contralateral side has to
be noted because it is not possible to exclude an occult
contralateral thrombus. Furthermore, occult secondary
events after the initial phase cannot be estimated. Sensitivity
of plethysmography is relatively high, but specificity is poor
and the role of plethysmography in observing the calf-
muscle pump function is not clear.28 On the other hand, all
Table IV. Presence of popliteal reflux after cDVT in










Reflux 8 (25%) 11 (73%)
No reflux 24 (75%) 4 (27%)
Total 32 (100%) 15 (100%)
Measurements are made with color-flow duplex scan imaging.
P  .05
Table V. Deep reflux detected in
photoplethysmographic measurements: Association









Deep reflux 8 (24%) 8 (50%)
No deep reflux 25 (76%) 8 (50%)
Total 33 (100%) 16 (100%)
P  .05.
Table VI. Association between photoplethysmography





Deep reflux in PPG 13 (68%) 3 (10%)
No deep reflux in PPG 6 (32%) 27 (90%)
Total 19 (100%) 30 (100%)
P  .05.
PPG, Photoplethysmography; CDFI, color flow duplex scan imaging.
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patients were studied clinically with a standardized classifi-
cation.11 Color-flow duplex scan imaging has been shown
to have a high sensitivity (91%), specificity (100%), and
accuracy (95%) when the measurements are performed in a
standing position and distal manual compression-release is
used.29 One entity that may have impact on outcome is the
lack of compression treatment in these data. Only one third
of the patients used stockings regularly after the initial
cDVT, and no supervision controlled the use of compres-
sion.
CONCLUSION
These data show a high proportion of postthrombotic
skin changes and deep popliteal reflux after isolated cDVT.
Popliteal vein may have an important role in the develop-
ment of the postthrombotic sequelae. Treatment with an-
ticoagulants has not prevented late manifestations in the
studied limbs. Further studies that observe the hemody-
namic changes in the outflow tract are needed, as are
studies on the effect of compression therapy in patients with
cDVT.
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